Polycef

Administered via slow intravenous (IV) injection, intermittent or continuous IV infusion, or deep intramuscular (IM) injection. Reconstitute powder with sterile water for injection, 0.9% sodium chloride injection, or other compatible diluents as per instructions.

Cefazolin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs). This leads to osmotic instability and bacterial cell lysis, resulting in bactericidal activity.

• Hypersensitivity to Cefazolin or any other cephalosporin antibiotics.
• History of severe hypersensitivity (e.g., anaphylaxis, severe skin reactions) to penicillins or other beta-lactam antibiotics.

Store intact vials below 30°C (86°F) in a dry place, protected from light. Keep out of reach of children. Reconstituted solutions have specific storage requirements as mentioned in the FAQ.

Symptoms of overdose may include nausea, vomiting, epigastric distress, diarrhea, and convulsions, particularly in patients with renal impairment. Management is primarily supportive; hemodialysis may be useful in removing the drug from the blood.

Pregnancy Category B. Studies in animals have not shown harm to the fetus, but adequate and well-controlled studies in pregnant women are lacking. Use during pregnancy only if clearly needed. Cefazolin is excreted in small amounts in breast milk; caution is advised when administering to a nursing mother.

• Hypersensitivity to Cefazolin or any other cephalosporin antibiotics.
• History of severe hypersensitivity (e.g., anaphylaxis, severe skin reactions) to penicillins or other beta-lactam antibiotics.

Store intact vials below 30°C (86°F) in a dry place, protected from light. Keep out of reach of children. Reconstituted solutions have specific storage requirements as mentioned in the FAQ.

Symptoms of overdose may include nausea, vomiting, epigastric distress, diarrhea, and convulsions, particularly in patients with renal impairment. Management is primarily supportive; hemodialysis may be useful in removing the drug from the blood.

Pregnancy Category B. Studies in animals have not shown harm to the fetus, but adequate and well-controlled studies in pregnant women are lacking. Use during pregnancy only if clearly needed. Cefazolin is excreted in small amounts in breast milk; caution is advised when administering to a nursing mother.